What question did this study set out to answer?

To evaluate the early mortality and complications associated with Transcatheter Aortic Valve Implantation in a large cohort.

January 23, 2026

Transcatheter Aortic Valve Implantation: Selection, Early Mortality, and Complications. A Multicenter Evaluation of More Than 33 000 Implantations (2013–2023).

Key Points

To evaluate the early mortality and complications associated with Transcatheter Aortic Valve Implantation in a large cohort.
Multicenter evaluation of more than 33,000 TAVI procedures between 2013 and 2023
Assessment of patient risk profiles and interventionist experience over time
Analysis of short-term results and mortality rates
Mortality rate remained stable over recent years
TAVI shows optimized outcomes for older patients
Increasing experience and procedure refinements contribute to improved short-term results

Abstract

The improved short-term results of TAVI from 2013 to 2023 are attributable to a change in patients' risk profiles as well as the increasing experience of the interventionists and refinements of the procedure. The mortality rate, which has remained unchanged in recent years, indicates that TAVI for older patients has been largely optimized.

Transcatheter Aortic Valve Implantation: Selection, Early Mortality, and Complications. A Multicenter Evaluation of More Than 33 000 Implantations (2013–2023).

Key Points

Abstract

Cite This Study